Genetic variation in IL28B (IFNL3) and response to interferon ‐alpha treatment in myeloproliferative neoplasms

ConclusionThese results imply an effect of IL28B genotype on the outcome of IFN‐α treatment in MPN.This article is protected by copyright. All rights reserved.

Source: European Journal of Haematology - January 25, 2018 Category: Hematology Authors: Marie Lindgren, Jan Samuelsson, Lars Nilsson, H åvar Knutsen, Waleed Ghanima, Johan Westin, Peter L Johansson, Björn Andréasson Tags: Original Article Source Type: research